Isom S - Search Results

1

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.

Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J. Lycan TW, et al. Among authors: isom s. PLoS One. 2016 Oct 12;11(10):e0164244. doi: 10.1371/journal.pone.0164244. eCollection 2016. PLoS One. 2016. PMID: 27732654 Free PMC article. Clinical Trial.

2

The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.

Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Ellis LR, Levitan D, Pardee TS, Isom S, Powell BL. Klepin HD, et al. Among authors: isom s. J Am Geriatr Soc. 2011 Oct;59(10):1837-46. doi: 10.1111/j.1532-5415.2011.03614.x. Epub 2011 Sep 13. J Am Geriatr Soc. 2011. PMID: 22091497 Free PMC article.

3

Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).

Tawfik B, Sliesoraitis S, Lyerly S, Klepin HD, Lawrence J, Isom S, Ellis LR, Manuel M, Dralle S, Berenzon D, Powell BL, Pardee T. Tawfik B, et al. Among authors: isom s. Ann Hematol. 2014 Jan;93(1):47-55. doi: 10.1007/s00277-013-1940-9. Epub 2013 Oct 23. Ann Hematol. 2014. PMID: 24149914 Free PMC article.

4

A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. Ayala-Peacock DN, et al. Among authors: isom s. Neuro Oncol. 2014 Sep;16(9):1283-8. doi: 10.1093/neuonc/nou018. Epub 2014 Feb 20. Neuro Oncol. 2014. PMID: 24558022 Free PMC article.

5

Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Lucas JT Jr, et al. Among authors: isom s. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):120-6. doi: 10.1016/j.ijrobp.2014.01.023. Epub 2014 Mar 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24613811 Free PMC article.

6

A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.

Pardee TS, Lee K, Luddy J, Maturo C, Rodriguez R, Isom S, Miller LD, Stadelman KM, Levitan D, Hurd D, Ellis LR, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. Pardee TS, et al. Among authors: isom s. Clin Cancer Res. 2014 Oct 15;20(20):5255-64. doi: 10.1158/1078-0432.CCR-14-1019. Epub 2014 Aug 27. Clin Cancer Res. 2014. PMID: 25165100 Free PMC article. Clinical Trial.

7

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer.

Cowherd S, Miller LD, Melin SA, Akman S, Isom S, Cole J, Pullikuth A, Lawrence JA. Cowherd S, et al. Among authors: isom s. Cancer Biol Ther. 2015;16(5):678-83. doi: 10.1080/15384047.2015.1026481. Cancer Biol Ther. 2015. PMID: 25928118 Free PMC article. Clinical Trial.

8

Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases?

Lucas JT Jr, Colmer HG 4th, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Lucas JT Jr, et al. Among authors: isom s. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1008-1015. doi: 10.1016/j.ijrobp.2015.04.032. Epub 2015 Apr 23. Int J Radiat Oncol Biol Phys. 2015. PMID: 26050609 Free PMC article.

9

Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Johnson AG, et al. Among authors: isom s. Oncotarget. 2015 Aug 7;6(22):18945-55. doi: 10.18632/oncotarget.4153. Oncotarget. 2015. PMID: 26087184 Free PMC article.

10

High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.

Ahmed T, Holwerda S, Klepin HD, Isom S, Ellis LR, Lyerly S, Manuel M, Dralle S, Berenzon D, Powell BL, Pardee TS. Ahmed T, et al. Among authors: isom s. Leuk Res. 2015 Sep;39(9):945-9. doi: 10.1016/j.leukres.2015.05.010. Epub 2015 Jun 1. Leuk Res. 2015. PMID: 26154683 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters